Contemporary Perspectives on J-Wave Syndromes: An Expert Consensus Statement

dc.contributor.authorNademanee K.
dc.contributor.authorWilde A.A.
dc.contributor.authorAckerman M.J.
dc.contributor.authorR. Behr E.
dc.contributor.authorBezzina C.R.
dc.contributor.authorChen P.S.
dc.contributor.authorChung F.P.
dc.contributor.authorCoronel R.
dc.contributor.authorHaissaguerre M.
dc.contributor.authorJiang C.
dc.contributor.authorJuang J.M.J.
dc.contributor.authorKhongphatthanayothin A.
dc.contributor.authorMakita N.
dc.contributor.authorMorita H.
dc.contributor.authorNakagawa H.
dc.contributor.authorNgarmukos T.
dc.contributor.authorNogami A.
dc.contributor.authorPappone C.
dc.contributor.authorPriori S.G.
dc.contributor.authorRosso R.
dc.contributor.authorShimizu W.
dc.contributor.authorVeerakul G.
dc.contributor.authorViskin S.
dc.contributor.correspondenceNademanee K.
dc.contributor.otherMahidol University
dc.date.accessioned2026-02-28T18:20:51Z
dc.date.available2026-02-28T18:20:51Z
dc.date.issued2026-02-01
dc.description.abstractJ-wave syndromes (JWS)—comprising Brugada syndrome (BrS) and early repolarization syndrome (ERS)—are important causes of malignant ventricular arrhythmias and sudden cardiac death in patients whose hearts appear structurally normal. Since the 2016 consensus, advances in genetics, pathophysiology, and therapy have redefined both understanding and management. BrS, once viewed as a purely electrical disorder, is now recognized along a microstructural–electrical continuum, with sodium-channel dysfunction and subtle epicardial fibrosis of the right ventricular outflow tract as key contributors. Likewise, ERS—historically considered benign—carries significant risk when inferolateral J-waves coexist with arrhythmic events. Genetically, SCN5A remains the sole gene with definitive disease association, while polygenic susceptibility materially modulates risk, underscoring complex inheritance. Risk stratification remains challenging: patients with prior cardiac arrest or arrhythmic syncope are highest risk, whereas asymptomatic individuals warrant multiparametric assessment integrating clinical features, ECG markers, electrophysiologic studies, and genetics. For decades, treatment centered on implantable cardioverter-defibrillators and quinidine, both limited by availability, tolerance, and device complications. More recently, epicardial substrate ablation has emerged as a transformative therapy, with large registries and randomized trials demonstrating durable suppression of ventricular fibrillation and acceptable safety. This APHRS-organized international consensus updates and extends the 2016 Expert Consensus and the 2022 ESC Guidelines, providing contemporary diagnostic frameworks, pragmatic risk-stratification tools, and treatment algorithms for BrS and ERS. It emphasizes JWS as a microstructural–electrical disease spectrum and elevates substrate ablation as a major therapeutic advance, while outlining priorities for genetics, risk-stratification and treatment algorithms.
dc.identifier.citationJournal of Arrhythmia Vol.42 No.1 (2026)
dc.identifier.doi10.1002/joa3.70284
dc.identifier.eissn18832148
dc.identifier.issn18804276
dc.identifier.scopus2-s2.0-105030707008
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/115444
dc.rights.holderSCOPUS
dc.subjectMedicine
dc.titleContemporary Perspectives on J-Wave Syndromes: An Expert Consensus Statement
dc.typeArticle
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105030707008&origin=inward
oaire.citation.issue1
oaire.citation.titleJournal of Arrhythmia
oaire.citation.volume42
oairecerif.author.affiliationMayo Clinic
oairecerif.author.affiliationUniversiteit van Amsterdam
oairecerif.author.affiliationTel Aviv University
oairecerif.author.affiliationCleveland Clinic Foundation
oairecerif.author.affiliationAmsterdam UMC - University of Amsterdam
oairecerif.author.affiliationUniversità degli Studi di Pavia
oairecerif.author.affiliationZhejiang University School of Medicine
oairecerif.author.affiliationNational Yang-Ming University Taiwan
oairecerif.author.affiliationNational Taiwan University Hospital
oairecerif.author.affiliationCedars-Sinai Medical Center
oairecerif.author.affiliationTaipei Veterans General Hospital
oairecerif.author.affiliationNational Taiwan University College of Medicine
oairecerif.author.affiliationUniversità Vita-Salute San Raffaele
oairecerif.author.affiliationNational Cerebral and Cardiovascular Center
oairecerif.author.affiliationIstituti Clinici Scientifici Maugeri Spa – SB
oairecerif.author.affiliationGruppo Ospedaliero San Donato
oairecerif.author.affiliationHopital Haut-Lévêque C.H.U de Bordeaux
oairecerif.author.affiliationSt George's University Hospitals NHS Foundation Trust
oairecerif.author.affiliationFaculty of Medicine, University of Tsukuba
oairecerif.author.affiliationFaculty of Medicine Ramathibodi Hospital, Mahidol University
oairecerif.author.affiliationFaculty of Medicine, Chulalongkorn University
oairecerif.author.affiliationAmsterdam Cardiovascular Sciences
oairecerif.author.affiliationFaculty of Medicine
oairecerif.author.affiliationInstitut de Rythmologie et Modélisation Cardiaque
oairecerif.author.affiliationNew Tokyo Hospital
oairecerif.author.affiliationCity St George's, University of London
oairecerif.author.affiliationBumrungrad International Hospital
oairecerif.author.affiliationSapporo Teishinkai Hospital
oairecerif.author.affiliationKey Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province
oairecerif.author.affiliationBangkok Heart Hospital
oairecerif.author.affiliationPacific Rim Electrophysiology Research Institute

Files

Collections